Media ReleasesVisioneering Technologies

View All Visioneering Technologies News


Visioneering Technologies Announces CE Mark Achieved for NaturalVue® Family of 1 Day Contact Lenses

Indications include unique NaturalVue Multifocal lens for myopia progression control

Atlanta, Georgia, USA 31 January 2018: Visioneering Technologies, Inc. (ASX:VTI), an innovative US-based medical device company dedicated to developing advanced products that improve vision, announced today receipt of European CE Mark (Conformité Européenne) for commercialization in the European Union of its portfolio of proprietary NaturalVue® (etafilcon A) brand 1 Day Contact Lenses, including Sphere, Toric, Multifocal and Multifocal Toric. VTI’s CE Mark includes an indication for VTI’s unique NaturalVue Multifocal (NVMF) for myopic progression control (the control of progressive nearsightedness). NVMF contact lenses feature VTI’s innovative Neurofocus Optics® Technology, which employs a patented extended depth-of-focus design to address known optical risk factors associated with myopia progression. The innovative NVMF lens design allows it to be used for both myopic progression control and presbyopia (the age-related loss of ability to see near objects).


For further information please download PDF attached: 
Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.